C12N 2501/65
Microrna
Official title: MicroRNA
C12N2501/65 (Microrna) appears on 137 US grants and 311 published applications in this corpus.
Search patents in C12N- Granted patents
- 137
- Published applications
- 311
- Assignees
- 199
- Inventors
- 640
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 13 |
| 2013 | 0 | 17 |
| 2014 | 8 | 11 |
| 2015 | 9 | 26 |
| 2016 | 12 | 17 |
| 2017 | 11 | 17 |
| 2018 | 13 | 24 |
| 2019 | 18 | 22 |
| 2020 | 9 | 24 |
| 2021 | 8 | 28 |
| 2022 | 13 | 34 |
| 2023 | 10 | 22 |
| 2024 | 10 | 21 |
| 2025 | 7 | 21 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for differentiating pluripotent stem cells into desired cell type25 Aug 2026US 12,716,053 B2Keio University
- Methods and composition for modulating immune response and immune homeostasis11 Aug 2026US 12,702,696 B2Massachusetts Institute of Technology
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- mRNA construct for protein expression and use of same26 May 2026US 12,637,689 B2Korea Research Institute of Bioscience and Biotechnology
- Methods and compositions for reprogramming cells14 Apr 2026US 12,600,968 B2The Regents of the University of Colorado, a body corporate
- Constructs for reprogramming of smooth muscle cells into endothelial cells20 Aug 2026US 2026/0242744 A1The Brigham and Women S Hospital, Inc.
- Compositions and Methods for Treating a Neurologic Disease Using Dopaminergic Neurons with Enhanced Anti-inflammatory Activity30 Jul 2026US 2026/0216250 A1Kenai Therapeutics, Inc.
- Genetically modified cells4 Jun 2026US 2026/0152722 A1Ivy Farm Technologies Limited
- Maturation of dendritic cells30 Apr 2026US 2026/0115227 A1Bioclones Proprietary Limited
- Enhancement of fibroblast plasticity for treatment of disc degeneration30 Apr 2026US 2026/0117185 A1SpinalCyte, LLC
Most cited
By later US patents
- Targeted RNA degradation using nuclear antisense RNA207US 5,908,779 AUniversity of Connecticut · 1999
- Targeted RNA degradation using nuclear ribozyme RNA21US 6,265,167 B12001
- Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells16US 10,487,314 B2The Trustees of Columbia University in the City of New York · 2019
- Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer8US 8,664,192 B2The Ohio State University · 2014
- Methods and compositions for the treatment of insulin-associated medical conditions8US 8,951,983 B2Yeda Research and Development Co. Ltd. · 2015